Stabilizers for reconstituted, lyophilized samples

Claim 2

A stabilized serum matrix or serum-derived composition comprising lipids, and a clarity stabilizer comprising a sugar, sugar amine, or sugar alcohol in at least an amount sufficient to measurably reduce the optical density of the composition, after lyophilization and reconstitution with water, below the optical density of said lyophilized and reconstituted matrix or composition lacking said stabilizer, when measured at 700 nm. using a 1 cm. path length.

Claim 3

A composition as defined in claim 1, wherein said stabilizer is present in an amount sufficient to maintain the optical density of the composition, after lyophilization and reconstitution with water, at a level comparable to the optical density of said composition prior to lyophilization, when measured at about 700 nm. using a 1 cm. path length.

Claim 4

A composition as defined in claim 2, wherein said stabilizer is present in an amount sufficient to render the reconstituted composition optically clear.

Claim 5

A stabilized serum matrix or serum-derived composition comprising lipids, and a clarity stabilizer selected from the group consisting of glucose, sucrose, lactose, arabinose, sorbitol, fructose, xylitol, mannitol, and glucosamine; said stabilizer being present in at least an amount sufficient to measurably reduce the optical density of the composition, after lyophilization and reconstitution with water, below the optical density of said lyophilized and reconstituted matrix or composition lacking said stabilizer, when measured at 700 nm. using a 1 cm. path length.

Claim 6

A stabilized serum matrix or serum-derived composition comprising lipids, and a clarity stabilizer selected from the group consisting of glucose, sucrose, lactose, arabinose, sorbitol, fructose, xylitol, mannitol, and glucosamine; said stabilizer being present in at least an amount sufficient to measurably reduce the optical density of the composition, after lyophilization and reconstitution with water, below the optical density of said lyophilized and reconstituted matrix or composition lacking said stabilizer, when measured at 700 nm. using a 1 cm. path length.

Claim 7

A composition as defined in claim 4, wherein said stabilizer is present in an amount sufficient to maintain the optical density of the composition, after lyophilization and reconstitution with water, at a level comparable to the optical density of the matrix or composition prior to lyophilization, when measured at about 700 nm. using a 1 cm. path length.

Claim 8

A serum assay standard, comprising a lipid selected from cholesterol, cholesterol esters and triglyceride; and a clarity stabilizer comprising a sugar, sugar amine, or sugar alcohol in at least an amount sufficient to measurably reduce the optical density of the standard, after lyophilization and reconstitution with water, below the optical density of said lyophilized and reconstituted standard lacking said stabilizer, when measured at 700nm. using a 1 cm. path length.

Claim 9

A serum assay standard, comprising a lipid selected from cholesterol, cholesterol esters and triglyceride; and a clarity stabilizer comprising a sugar, sugar amine, or sugar alcohol in at least an amount sufficient to measurably reduce the optical density of the standard, after lyophilization and reconstitution with water, below the optical density of said lyophilized and reconstituted standard lacking said stabilizer, when measured at 700nm. using a 1 cm. path length.

Claim 10

A standard as defined in claim 6, wherein said stabilizer is present in an amount sufficient to maintain the optical density of the standard, after lyophilization and reconstitution with water, at a level comparable to the optical density of the matrix or composition prior to lyophilization, when measured at about 700 nm. using a 1 cm. path length.

Claim 11

A standard as defined in claim 7, wherein said stabilizer is present in an amount sufficient to render the reconstituted standard optically clear.

Claim 12

A serum assay standard comprising a lipid selected from cholesterol, cholesterol esters, and triglyceride; and a clarity stabilizer selected from the group consisting of glucose, sucrose, lactose, arabinose, sorbitol, xylitol, mannitol, and glucosamine; said stabilize being present in at least an amount sufficient to measurably reduce the optical density of the standard, after lyophilization and reconstitution with water, below the optical density of said lyophilized and reconstituted standard lacking said stabilizer, when measured at 700 nm. using a 1 cm. path length.

Claim 13

A serum assay standard comprising a lipid selected from cholesterol, cholesterol esters, and triglyceride; and a clarity stabilizer selected from the group consisting of glucose, sucrose, lactose, arabinose, sorbitol, xylitol, mannitol, and glucosamine; said stabilize being present in at least an amount sufficient to measurably reduce the optical density of the standard, after lyophilization and reconstitution with water, below the optical density of said lyophilized and reconstituted standard lacking said stabilizer, when measured at 700 nm. using a 1 cm. path length.

Claim 14

A standard as defined in claim 9, wherein said stabilizer is present in an amount sufficient to maintain the optical density of the standard, after lyophilization and reconstitution with water, at a level comparable to the optical density of the matrix or composition prior to lyophilization, when measured at about 700 nm. using a 1 cm. path length.

Claim 15

A standard as defined in claim 10, wherein said stabilizer is present in an amount sufficient to render the reconstituted standard optically clear.

Claim 16

In a method of maintaining homogeneity in a lipid-containing serum matrix or serum-derived composition, wherein said matrix or composition is lyophilized and then reconstituted; the improvement comprising the step of adding to said matrix or composition prior to the lyophilization step, a clarity stabilizer comprising a sugar, sugar amine, or sugar alcohol in at least an amount sufficient to measurably reduce the optical density of the composition, after lyophilization and reconstitution with water, below the optical density of said lyophilized and reconstituted matrix or composition lacking said stabilizer, when measured at 700 nm. using a 1 cm. path length; whereby upon reconstitution with water said matrix or composition has a reduced amount of turbidity.

Claim 17

In a method of maintaining homogeneity in a lipid-containing serum matrix or serum-derived composition, wherein said matrix or composition is lyophilized and then reconstituted; the improvement comprising the step of adding to said matrix or composition prior to the lyophilization step, a clarity stabilizer comprising a sugar, sugar amine, or sugar alcohol in at least an amount sufficient to measurably reduce the optical density of the composition, after lyophilization and reconstitution with water, below the optical density of said lyophilized and reconstituted matrix or composition lacking said stabilizer, when measured at 700 nm. using a 1 cm. path length; whereby upon reconstitution with water said matrix or composition has a reduced amount of turbidity.